Pliant Therapeutics, Inc. · NASDAQ:PLRX
Point72 Asset Management, L.P. reported a 6.70% stake in Pliant Therapeutics, Inc. (Schedule 13G)
Event Aug 27, 2025 · Filed Sep 4, 2025
Point72 Asset Management, L.P. reported a 6.70% stake in Pliant Therapeutics, Inc., 4,085,017 shares, as a passive investor on Aug 27, 2025. Filed Sep 4, 2025 (Schedule 13G).
- Stake
- 6.70%
- Shares
- 4,085,017
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Point72 Asset Management, L.P. | 6.70% | 4,085,017 |
| Point72 Capital Advisors, Inc. | 6.70% | 4,085,017 |
| Steven A. Cohen | 6.70% | 4,085,017 |
Source
Related
- Pliant Therapeutics, Inc.
- Point72 Asset Management, L.P.
- Pliant Therapeutics, Inc. shareholders
- Schedule 13G/A · Point72 Asset Management, L.P. · Feb 17, 2026
- Schedule 13G/A · Citadel Advisors LLC · Aug 14, 2026
- Schedule 13G · ADAR1 Capital Management, LLC · Aug 14, 2026
- Schedule 13G/A · Woodline Partners LP · Feb 17, 2026
- Schedule 13G · Citadel Advisors LLC · Feb 9, 2026
- Schedule 13G · Citadel Advisors LLC · Jan 30, 2026